Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Hydatidiform Mole × Dactinomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rhabdomyosarcoma 7 Sarcoma 6 Malignant mesenchymal tumor 4 Wilms Tumor 3 Sarcoma, Ewing 1 Rhabdomyosarcoma, Embryonal 1 Pleuropulmonary blastoma 1 Kidney Neoplasms 1 Hydatidiform Mole 1 Gestational Trophoblastic Disease 1 Fibrosarcoma 1 Carcinoma, Renal Cell 1 Beckwith-Wiedemann Syndrome 1

Interventions

merphos 1 Methotrexate 1 Dactinomycin 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003702 2018-05-15

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed

240 enrolled 9 charts

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon ⚡